Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-15 Sale |
2021-12-17 5:13 pm |
Nuvation Bio Inc. | NUVB | Omega Fund V L.P. Omega Fund IV GP L.P. Omega Fund V GP Manager Ltd. 10% Owner |
500,000 | $10.07 | $5,035,000 | 22,957,340 (Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 3:59 pm |
Nuvation Bio Inc. | NUVB | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. 10% Owner |
1,400,000 | $9.8 | $13,720,000 | 23,457,340 (Direct) |
View |
| 2021-03-31 Purchase |
2021-11-30 6:07 pm |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director |
393,168 | $8.8887 | $3,494,733 | 6,534,868 (Indirect) |
View |
| 2021-03-31 Sale |
2021-11-30 6:07 pm |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director |
208,142 | $9.9578 | $2,072,642 | 6,534,868 (Indirect) |
View |
| 2021-11-22 Sale |
2021-11-24 6:38 pm |
Nuvation Bio Inc. | NUVB | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. 10% Owner |
295,036 | $9.76 | $2,879,551 | 24,857,376 (Direct) |
View |
| 2021-11-03 Sale |
2021-11-05 5:31 pm |
Nuvation Bio Inc. | NUVB | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. 10% Owner |
2,000,000 | $9.25 | $18,500,000 | 25,152,376 (Direct) |
View |
| 2021-10-28 Sale |
2021-11-01 5:01 pm |
Nuvation Bio Inc. | NUVB | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. 10% Owner |
1,060,000 | $9.586 | $10,161,150 | 27,152,376 (Direct) |
View |
| 2021-04-09 Purchase |
2021-04-13 5:55 pm |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Panacea Holdings LLC Biotech Opportunity GP LLC Director |
464,500 | $9.8915 | $4,594,594 | 6,721,252 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-04-01 5:16 pm |
Nuvation Bio Inc. | NUVB | Bazemore Robert B Director |
5,000 | $9.9799 | $49,900 | 5,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-28 Option Award |
2022-03-02 2:32 pm |
N/A 2032-02-27 |
Nuvation Bio Inc. | NUVB | Fox Jennifer A. Chief Financial Officer |
600,000 | $0 | 601,706 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 2:29 pm |
N/A 2032-02-27 |
Nuvation Bio Inc. | NUVB | Hung David President and CEO 10% Owner |
2,000,000 | $0 | 60,646,800 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 9:37 pm |
N/A 2031-10-28 |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG Director 10% Owner |
45,229 | $0 | 45,229 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 9:33 pm |
N/A 2031-10-28 |
Nuvation Bio Inc. | NUVB | BLICKENSTAFF KIM D Director |
45,229 | $0 | 45,229 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 9:31 pm |
N/A 2031-10-28 |
Nuvation Bio Inc. | NUVB | WELCH DANIEL G Director |
45,229 | $0 | 45,229 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 9:30 pm |
N/A 2031-10-28 |
Nuvation Bio Inc. | NUVB | VERNON W ANTHONY Director |
45,229 | $0 | 45,229 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 9:29 pm |
N/A 2031-10-28 |
Nuvation Bio Inc. | NUVB | FALBERG KATHRYN E Director |
45,229 | $0 | 45,229 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-02 9:29 pm |
N/A 2031-10-28 |
Nuvation Bio Inc. | NUVB | Bazemore Robert B Director |
45,229 | $0 | 45,229 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 6:36 pm |
N/A 2031-05-31 |
Nuvation Bio Inc. | NUVB | Hanley David C. Chief Technical Operations |
437,500 | $0 | 437,500 (Direct) |
View |
| 2021-03-09 Option Award |
2021-03-11 4:35 pm |
N/A 2031-03-08 |
Nuvation Bio Inc. | NUVB | Hung David President and CEO 10% Owner |
390,225 | $0 | 390,225 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-26 7:02 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Sharp Shalini Director |
25,000 | $0 | 35,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-26 7:02 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Sharp Shalini Director |
10,000 | $10 | 35,000 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-26 7:01 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | BRADBURY DANIEL Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-26 7:00 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Hasnain Faheem Director |
25,000 | $0 | 55,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-26 7:00 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Hasnain Faheem Director |
30,000 | $10 | 55,000 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-26 6:59 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | COOPER GRAHAM K Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:59 pm |
2021-07-06 N/A |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Panacea Holdings LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
8,545,350 | $0 | 3,163,960 (Indirect) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:59 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Panacea Holdings LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
2,500,000 | $10 | 3,163,960 (Indirect) |
View |
| 2021-02-10 Conversion |
2021-02-12 8:59 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Panacea Holdings LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
2,775,000 | $0 | 3,163,960 (Indirect) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:59 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari DOIG MICHELLE 10% Owner |
500,000 | $10 | 28,212,373 (Direct) |
View |
| 2021-02-10 Conversion |
2021-02-12 5:59 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari DOIG MICHELLE 10% Owner |
8,130,097 | $0 | 28,212,373 (Direct) |
View |
Ownership |
2021-02-12 5:58 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari DOIG MICHELLE 10% Owner |
0 | $0 | 0 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:56 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | VERNON W ANTHONY Director |
493,461 | $0 | 543,461 (Direct) |
View |
| 2020-02-10 Option Award |
2021-02-12 5:56 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | VERNON W ANTHONY Director |
50,000 | $10 | 543,461 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:55 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | FALBERG KATHRYN E Director |
239,361 | $0 | 239,361 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:54 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | BLICKENSTAFF KIM D Director |
239,361 | $0 | 239,361 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:53 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | Bazemore Robert B Director |
239,361 | $0 | 239,361 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:51 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | WELCH DANIEL G Director |
398,934 | $0 | 398,934 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:50 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | Markel Stacy SVP, Human Resources |
653,745 | $0 | 653,745 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:48 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | Templeman Thomas SVP, Pharmaceutical Ops |
797,870 | $0 | 797,870 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:47 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | Hattersley Gary Chief Scientific Officer |
797,870 | $0 | 797,870 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:46 pm |
N/A 2030-10-04 |
Nuvation Bio Inc. | NUVB | Yurasov Sergey Chief Medical Officer |
797,870 | $0 | 797,870 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:46 pm |
N/A 2030-10-11 |
Nuvation Bio Inc. | NUVB | Fox Jennifer A. Chief Financial Officer |
957,441 | $0 | 957,441 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:45 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Hung David President and CEO 10% Owner |
57,645,012 | $0 | 59,645,012 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:45 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Hung David President and CEO 10% Owner |
2,000,000 | $10 | 59,645,012 (Direct) |
View |
Ownership |
2021-02-12 5:39 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | VERNON W ANTHONY Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-02-12 5:39 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | FALBERG KATHRYN E Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-02-12 5:37 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | BLICKENSTAFF KIM D Director |
0 | $0 | 0 (Direct) |
View |